Download PDF
1 / Pages

Other users also viewed these articles

Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment Francisco José de la Prada Álvarez; Melissa Cintra Cabrera; Marina Almenara Tejederas; Javier Burgos Martin; Fabiola Alonso García; Mercedes Salgueira Lazo;
Nefrologia (English Version). 2024;44:306-7
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? Teresa Arrobas Velilla; Carlos Guijarro; Raquel Campuzano Ruiz; Manuel Rodríguez Piñero; José Francisco Valderrama Marcos; Antonio M. Botana López; Ana Morais López; José Antonio García Donaire; Juan Carlos Obaya; Luis Castilla Guerra; Vicente Pallares Carratalá; Isabel Egocheaga Cabello; Mercedes Salgueira Lazo; María Mar Castellanos Rodrigo; José María Mostaza Prieto; Juan José Gómez Doblas; Antonio Buño Soto;
Nefrologia (English Version). 2023;43:474-83
More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia Juan Antonio Martín Navarro; Melissa Cintra Cabrera; Fabio Proccacini; Jorge Muñoz Rodríguez; David Roldán Cortés; Rafael Lucena Valverde; Mayra Ortega Díaz; Marta Puerta Carretero; Juana Gil Herrera; Maria Teresa Jaldo Rodríguez; Marta Albalate Ramón; Elena Corchete Prats; Laura Medina Zahonero; Patricia de Sequera Ortiz; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2022;42:94-8